Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment.
Stefano Strano1, Alessandra Fanciulli2, Massimiliano Rizzo1
1Department of Heart and Great Vessels "A. Reale", Sapienza University of Rome, Italy.
Journal of the Neurological Sciences
|October 25, 2016
Summary
Early Parkinson's disease (PD) affects cardiovascular autonomic function, showing reduced heart rate variability and exercise intolerance. This suggests sympathetic denervation may contribute to early symptoms in PD patients.
Area of Science:
- Neurology
- Cardiology
- Autonomic Function Testing
Background:
- Parkinson's disease (PD) presents with diverse non-motor symptoms, including cardiovascular autonomic dysfunction.
- Early identification of autonomic issues is crucial for managing PD progression.
Purpose of the Study:
- To assess cardiovascular autonomic status in newly diagnosed, drug-naïve Parkinson's disease patients.
- To evaluate cardiac functional capacity and autonomic responses to stimuli.
Main Methods:
- Cardiovascular autonomic function tests (R-R interval, BP variability, baroreflex sensitivity) were performed.
- Echocardiography, spirometry, cardiopulmonary exercise testing (CPET), and MIBG scintigraphy were utilized.
- 18 drug-naïve PD patients and controls were included in the study.
Main Results:
- PD patients exhibited lower heart rate variability at rest compared to controls.
- Mild exercise intolerance was noted in PD patients during CPET.
- Cardiac sympathetic denervation was suggested by impaired MIBG uptake in most PD patients.
Conclusions:
- Cardiovascular autonomic failure is present even in early-stage Parkinson's disease.
- Impaired cardiac sympathetic function may contribute to exercise intolerance in PD.
- Further research is needed to differentiate autonomic dysfunction from motor impairment effects on physical deconditioning.
Related Concept Videos
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Cardiomyopathy II: Dilated Cardiomyopathy
700
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
700
Peripheral Artery Disease I: Introduction
542
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
542
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
575
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
575
Peripheral Artery Disease III: Interprofessional Care
486
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486


